Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
94.2M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
44.3M
-
Shares change
-
+8.73M
-
Total reported value, excl. options
-
$1.26B
-
Value change
-
+$252M
-
Number of buys
-
83
-
Number of sells
-
-24
-
Price
-
$28.41
Significant Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q4 2021
120 filings reported holding CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock as of Q4 2021.
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.3M shares
of 94.2M outstanding shares and own 47.01% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (5.16M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (4.79M shares), FMR LLC (3.72M shares), BlackRock Inc. (3.28M shares), ORBIMED ADVISORS LLC (3.2M shares), BVF INC/IL (3M shares), VANGUARD GROUP INC (2.1M shares), Bain Capital Life Sciences Investors, LLC (2.03M shares), Deep Track Capital, LP (1.9M shares), and FRAZIER MANAGEMENT LLC (1.38M shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.